XSpray Pharma AB (OSTO:XSPRAY) Construction In Progress : kr41.39 Mil (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is XSpray Pharma AB Construction In Progress?

XSpray Pharma AB's quarterly construction in progress declined from Sep. 2024 (kr64.15 Mil) to Dec. 2024 (kr41.39 Mil) but then stayed the same from Dec. 2024 (kr41.39 Mil) to Mar. 2025 (kr41.39 Mil).

XSpray Pharma AB's annual construction in progress increased from Dec. 2022 (kr46.57 Mil) to Dec. 2023 (kr59.37 Mil) but then declined from Dec. 2023 (kr59.37 Mil) to Dec. 2024 (kr41.39 Mil).

XSpray Pharma AB Construction In Progress Historical Data

The historical data trend for XSpray Pharma AB's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XSpray Pharma AB Construction In Progress Chart

XSpray Pharma AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Construction In Progress

Get a 7-Day Free Trial

15.75

20.04

46.57

59.37

41.39

XSpray Pharma AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Construction In Progress	Get a 7-Day Free Trial															59.73	63.89	64.15	41.39	41.39

XSpray Pharma AB Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

XSpray Pharma AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XSpray Pharma AB (OSTO:XSPRAY) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

0GHZ:UK

Address

Scheeles vag 2, Solna, SWE, SE-171 65

Website

https://www.xspraypharma.com

XSpray Pharma AB is a pharmaceutical company focused on developing improved PKIs for cancer treatment, leveraging its proprietary HyNap technology platform. The company aims to enhance clinical outcomes for cancer patients by improving the efficacy, safety, and patient experience of existing cancer therapies. Its product portfolio includes Dasynoc and other product candidates in different stages of development such as XS003 nilotinib, XS008 axitinib, and other.

XSpray Pharma AB Headlines

No Headlines